Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017

The decline in the proportion of pneumococcal conjugate vaccine (PCV)–covered serotypes among adult invasive pneumococcal disease (IPD) patients might change the overall effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) because its effectiveness differs according to serotyp...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Emerg Infect Dis
Главные авторы: Shimbashi, Reiko, Suzuki, Motoi, Chang, Bin, Watanabe, Hiroshi, Tanabe, Yoshinari, Kuronuma, Koji, Oshima, Kengo, Maruyama, Takaya, Takeda, Hiroaki, Kasahara, Kei, Fujita, Jiro, Nishi, Junichiro, Kubota, Tetsuya, Tanaka-Taya, Keiko, Matsui, Tamano, Sunagawa, Tomimasa, Oishi, Kazunori
Формат: Artigo
Язык:Inglês
Опубликовано: Centers for Disease Control and Prevention 2020
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7510723/
https://ncbi.nlm.nih.gov/pubmed/32946721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2610.191531
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы